Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
NCT01396343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1276
Last updated 2018-10-18
Summary
The purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or environmental exposures or a combination of both put children and adolescents at risk for getting MS.
Conditions
- Pediatric Multiple Sclerosis
Sponsors & Collaborators
-
New York University
collaborator OTHER -
Massachusetts General Hospital
collaborator OTHER -
State University of New York at Buffalo
collaborator OTHER -
University of Alabama at Birmingham
collaborator OTHER - collaborator OTHER
-
Children's Hospital of Philadelphia
collaborator OTHER - collaborator OTHER
-
Baylor College of Medicine
collaborator OTHER -
Loma Linda University
collaborator OTHER -
Children's Hospital Colorado
collaborator OTHER -
University of Texas
collaborator OTHER -
Ann & Robert H Lurie Children's Hospital of Chicago
collaborator OTHER -
Washington University School of Medicine
collaborator OTHER -
Children's National Research Institute
collaborator OTHER -
Primary Children's Hospital
collaborator OTHER -
The Cleveland Clinic
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Emmanuelle L Waubant, MD, PhD · University of California, San Francisco
Eligibility
- Min Age
- 3 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- United States
Study Locations
More Related Trials
-
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
NCT02201108 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT02428218 ·Status: WITHDRAWN ·Phase: PHASE3
-
Obesity and Pediatric Multiple Sclerosis
NCT04593082 ·Status: ACTIVE_NOT_RECRUITING
-
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil
NCT03087136 ·Status: ACTIVE_NOT_RECRUITING
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri
NCT02137109 ·Status: COMPLETED
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
NCT01617395 ·Status: COMPLETED
-
Mobile Attentional Bias Modification Training in Pediatric MS
NCT04441229 ·Status: COMPLETED ·Phase: NA
-
Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
NCT06718920 ·Status: RECRUITING
-
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT02283853 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
T Cell Profiling in Patients with Multiple Sclerosis
NCT04789551 ·Status: NOT_YET_RECRUITING
-
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
NCT06735248 ·Status: RECRUITING ·Phase: PHASE2
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
DTI in Children With Multiple Sclerosis
NCT02361697 ·Status: UNKNOWN ·Phase: NA
-
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
NCT03111394 ·Status: COMPLETED
-
Stress Management for Patients With Multiple Sclerosis
NCT00147446 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT02555215 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
NCT02326935 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
NCT02200718 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
NCT04261790 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
NCT06715436 ·Status: RECRUITING ·Phase: NA